(Q84078596)
Statements
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial (English)
Eric Van Cutsem
Sanne de Haas
Yoon-Koo Kang
Niall C Tebbutt
Jian Ming Xu
Wei Peng Yong
Bernd Langer
Stefan J Scherer